Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Cost Control”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 523 records · Page 29Linked to original sources

[Unconventional medical procedures--a contribution to cost control?].

Firstly, it is explained that doctors, in accordance with the "Bundesmantelvertrag" and the so-called "Wissenschaftsklausel" of private insurance companies, are required to attend to cost-saving treatment and prescriptions, and that these regulations are also valid with regard to unconventional medical methods and medications. Further, it is exemplified by quotations, how some adherents of unconventional methods assert excessive pretension towards the general public as well as in medical periodicals. Accordingly, high fees are asked, which is also illustrated by some examples. Finally, users as well as non-users of disputed medical methods are called upon to occupy themselves more intensively with these problems and not to leave their solution to insurance bodies and the courts.

Complementary Therapies↗

Examining nursing personnel costs: controlled versus noncontrolled oral analgesic agents.

To date, few evaluations have focused on nursing personnel costs generated by practices of other clinicians. The authors used traditional industrial engineering and cost accounting techniques to determine nursing personnel costs generated by the use of controlled versus noncontrolled oral analgesic agents. The findings indicate that additional nursing labor costs are generated for drug administration and inventory activities for controlled agents when compared with noncontrolled agents. On an annual basis, the additional costs for drug administration generate approximately +34,000 in hospital expenses for the three nursing units included in this evaluation. This type of interdisciplinary investigation may be valuable as nursing departments face increasing pressures to decrease costs by reducing overtime and eliminating positions.

Algorithms↗

The role of the hospital pharmacist in cost control and antibiotic policy.

The pharmacist provides a vital role in the management of antibiotic policy. Consumers and payers demand quality care at a significantly reduced price. It is imperative that health care adapt to the times. Physicians must be involved in all phases of programmes that are viewed as cost saving. These programmes should integrate and document both clinical and financial aspects of care.

Anti-Bacterial Agents↗

Hospital's resource management program uses data to fuel cost control, quality improvement.

A behind-the-scenes look at Mt. Diablo Medical Center's data-driven clinical resource management program shows how this California provider got control of overhead, admission rates, LOS, and resource utilization. See how they used data to target areas for quality improvement and cost cutting, and linked QI initiatives throughout the organization. Plus, see their scoring system and benchmark data.

Benchmarking↗

Can a hospital be like a supermarket? Better data will provide cost controls, efficiencies, and income streams.

Electronic bar coding, scanning, and the data generated are an inevitable part of a health care provider's future. Initially, it will probably be implemented in hospitals, where the diversity of products and scrutiny to reduce costs are greatest. Many lessons can be learned from the introduction of electronic scanning in the grocery or supermarket industry. The transformation to scanning in the grocery industry met with initial resistance and problems, but generated creative solutions, best practices, and a rich database.

Cost Allocation↗

Cost control of therapy for i.v. catheter infections.

Intravenous catheter sepsis is an important challenge for physicians because it is associated with a high incidence of complications, and treatment can be very costly. Significant complications occur in about 25% of cases and include septic shock, suppurative thrombophlebitis, metastatic infection, and endocarditis. The risk of such complications is increased when catheter removal or appropriate antibiotic therapy is delayed, when Staphylococcus aureus is the pathogen, and probably when a prosthetic heart valve or pulmonary artery catheter is present. The optimum duration of antibiotic therapy for intravenous catheter sepsis has not been established and depends on the pathogen and on the presence of other risk factors for complications. A treatment duration of 1 week may be adequate for pathogens, such as coagulase-negative staphylococci or Candida, that are unlikely to cause complications, while > or = 2 weeks of antibiotic therapy is warranted for S aureus. Recent approaches that may help to reduce costs include shortening the duration of parenteral antibiotic treatment either by giving oral agents for part of the treatment period or by using a synergistic combination of antibiotics. Also, for infections in subcutaneously tunneled catheters, intraluminal administration of small volumes of highly concentrated antibiotics often is an effective alternative to prolonged systemic antibiotic therapy.

Anti-Bacterial Agents↗

Does case management matter as a hospital cost-control strategy?

Using an evidence-based model for management research, we examine the relationship of case management adoption and the expected nonclinical outcomes in nationwide hospitals operating continuously between 1994 and 2000. Although case management may be beneficial for certain populations, institution-wide effects in the form of decreased costs or decreased length of stay do not appear to be present in the study hospitals.

Case Management↗